Andreidesz, K.; Koszegi, B.; Kovacs, D.; Bagone Vantus, V.; Gallyas, F.; Kovacs, K.
Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells. Int. J. Mol. Sci. 2021, 22, 2056.
https://doi.org/10.3390/ijms22042056
AMA Style
Andreidesz K, Koszegi B, Kovacs D, Bagone Vantus V, Gallyas F, Kovacs K.
Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences. 2021; 22(4):2056.
https://doi.org/10.3390/ijms22042056
Chicago/Turabian Style
Andreidesz, Kitti, Balazs Koszegi, Dominika Kovacs, Viola Bagone Vantus, Ferenc Gallyas, and Krisztina Kovacs.
2021. "Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells" International Journal of Molecular Sciences 22, no. 4: 2056.
https://doi.org/10.3390/ijms22042056
APA Style
Andreidesz, K., Koszegi, B., Kovacs, D., Bagone Vantus, V., Gallyas, F., & Kovacs, K.
(2021). Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences, 22(4), 2056.
https://doi.org/10.3390/ijms22042056
